India to Peru: Raltegravir Export Trade Route

The India to Peru Raltegravir corridor is one of India's established pharmaceutical export routes, with 7 shipments documented worth a combined $1.9M USD. The route is dominated by HETERO LABS LIMITED , which alone accounts for roughly 61% of all export value, reflecting the consolidated nature of India's raltegravir manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $276.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with raltegravir's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 33.6%, placing it at rank #5 among India's top raltegravir export destinations globally.

On the import side, key buyers of Indian raltegravir in Peru include CENTRO NACIONAL DE ABASTECIMIENTO , N.P.C.SAC., TO THE ORDER OF and 2 others. CENTRO NACIONAL DE ABASTECIMIENTO is the single largest importer with 1 shipments valued at $931.1K USD.

India's raltegravir exports to Peru are driven primarily by a handful of large-scale manufacturers. HETERO LABS LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Peru benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — HETERO LABS LIMITED , TITAN LABORATORIES PRIVATE LIMITED, HETERO LABS LIMITED — together account for 99% of total trade value on this route. The average shipment value of $276.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as raltegrar (raltegravir tablets usp 400 mg) (8448 bottles of 60 t (506880 tablets) ) and raltegravir potassium tablet (raltavir), suggesting that buyers in Peru tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, CENTRO NACIONAL DE ABASTECIMIENTO is the largest importer with 1 shipments worth $931.1K USD — representing 48% of all raltegravir imports from India on this route.